Pat Cotroneo
2017
In 2017, Pat Cotroneo earned a total compensation of $2.8M as Chief Financial Officer at FibroGen, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $249,150 |
|---|---|
| Option Awards | $1,072,331 |
| Salary | $453,000 |
| Stock Awards | $971,169 |
| Other | $17,276 |
| Total | $2,762,926 |
Cotroneo received $1.1M in option awards, accounting for 39% of the total pay in 2017.
Cotroneo also received $249.2K in non-equity incentive plan, $453K in salary, $971.2K in stock awards and $17.3K in other compensation.
Rankings
In 2017, Pat Cotroneo's compensation ranked 3,970th out of 14,666 executives tracked by ExecPay. In other words, Cotroneo earned more than 72.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,970 out of 14,666 | 73rd |
Division Manufacturing | 1,390 out of 5,768 | 76th |
Major group Chemicals And Allied Products | 400 out of 2,074 | 81st |
Industry group Drugs | 309 out of 1,730 | 82nd |
Industry Pharmaceutical Preparations | 247 out of 1,329 | 81st |
Source: SEC filing on April 24, 2018.
Cotroneo's colleagues
We found two more compensation records of executives who worked with Pat Cotroneo at FibroGen in 2017.